Search Results - "DAZA, A. V"
-
1
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
Published in British journal of pharmacology (01-09-2006)“…Background and purpose: The CB2 receptor has been proposed as a novel target for the treatment of pain, and CB2 receptor agonists defined in in vitro assays…”
Get full text
Journal Article -
2
In vitro and in vivo characterization of A‐796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
Published in British journal of pharmacology (01-01-2008)“…Background and purpose: Selective cannabinoid CB2 receptor agonists have demonstrated analgesic activity across multiple preclinical pain models. AM1241 is an…”
Get full text
Journal Article -
3
Peripheral and central sites of action for the non‐selective cannabinoid agonist WIN 55,212‐2 in a rat model of post‐operative pain
Published in British journal of pharmacology (01-06-2009)“…Background and purpose: Activation of cannabinoid (CB) receptors decreases nociceptive transmission in inflammatory or neuropathic pain states. However, the…”
Get full text
Journal Article -
4
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB 2 receptor?
Published in British journal of pharmacology (29-01-2009)Get full text
Journal Article -
5
-
6
Bronchial and alveolar allergen-induced anaphylaxis and the stimulation of bronchial mucociliary clearance in ragweed-sensitized dogs
Published in Proceedings of the Association of American Physicians (01-07-1997)“…In allergic airways disease, we hypothesized that an acute allergen inhalation activates cells in the bronchial and alveolar regions of the lungs to initiate…”
Get more information
Journal Article -
7
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Published in The Journal of pharmacology and experimental therapeutics (01-10-2002)“…Alterations in the myogenic activity of the bladder smooth muscle are thought to serve as a basis for the involuntary detrusor contractions associated with the…”
Get more information
Journal Article -
8
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB sub(2) receptor agonist exhibiting analgesic activity in rodent pain models
Published in British journal of pharmacology (01-01-2008)“…Background and purpose: Selective cannabinoid CB sub(2) receptor agonists have demonstrated analgesic activity across multiple preclinical pain models. AMI 241…”
Get full text
Journal Article -
9
-
10
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB sub(2) receptor?
Published in British journal of pharmacology (01-09-2006)“…Background and purpose: The CB sub(2) receptor has been proposed as a novel target for the treatment of pain, and CB sub(2) receptor agonists defined in in…”
Get full text
Journal Article -
11
Spontaneous phasic activity of the pig urinary bladder smooth muscle: characteristics and sensitivity to potassium channel modulators
Published in British journal of pharmacology (01-02-2002)“…A hallmark for unstable bladder contractions is hyperexcitability and changes in the nature of spontaneous phasic activity of the bladder smooth muscle. In…”
Get full text
Journal Article -
12
Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral function
Published in Life sciences (1973) (30-11-2001)“…A-204176 (N-[5-(1H-imidazol-4-y1)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide) is a potent and selective alpha1A adrenoceptor agonist that binds with…”
Get full text
Journal Article -
13
Functional characterization of large conductance calcium-activated K+ channel openers in bladder and vascular smooth muscle
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-05-2004)“…Calcium activated K(+) channels (K(Ca) channels) are found in a variety of smooth muscle tissues, the most characterized of which are the large conductance…”
Get full text
Journal Article -
14
Synthesis and Structure−Activity Relationships of a Novel Series of 2,3,5,6,7,9-Hexahydrothieno[3,2- b ]quinolin-8(4 H )-one 1,1-Dioxide K ATP Channel Openers: Discovery of (−)-(9 S )-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2- b ]quinolin-8(4 H )-one 1,1-Dioxide (A-278637), a Potent K ATP Opener That Selectively Inhibits Spontaneous Bladder Contractions
Published in Journal of medicinal chemistry (03-06-2004)Get full text
Journal Article -
15
-
16
In vitro and in vivo characterization of a novel naphthylamide ATP‐sensitive K+ channel opener, A‐151892
Published in British journal of pharmacology (01-09-2004)“…Openers of ATP‐sensitive K+ channels are of interest in several therapeutic indications including overactive bladder and other lower urinary tract disorders…”
Get full text
Journal Article -
17
ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes
Published in European journal of pharmacology (02-08-2002)“…N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide, maleate (ABT-866) is a novel alpha(1)-adrenoceptor agent with mixed pharmacological properties in vitro…”
Get full text
Journal Article -
18
Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist
Published in Journal of medicinal chemistry (03-06-2004)“…Structure-activity studies were performed on the alpha(1A)-adrenoceptor (AR) selective agonist…”
Get full text
Journal Article -
19
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine
Published in Journal of medicinal chemistry (26-09-2002)“…N-[3-(1H-Imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1) is a novel alpha(1) agent having the unique profile of alpha(1A) (rabbit urethra, EC(50) =…”
Get full text
Journal Article -
20
Excitatory and Inhibitory Neural Regulation of Tracheal Ciliary Beat Frequency (CBF) Activated by Ammonia Vapour and SO2
Published in The Annals of occupational hygiene (01-01-1997)Get full text
Journal Article